Can immune checkpoint drugs fight cancers beyond their approved uses?
NCT ID NCT07754292
First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time
Summary
This phase 2 trial investigates whether immune checkpoint inhibitors—medicines that help the immune system attack cancer—can be effective when used off-label for different types of malignancies. Adults with cancer whose doctor is considering such treatment may join. Participants receive one of several ICI regimens, possibly combined with other therapies, and researchers track tumor response, side effects, and how long the disease stays controlled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- immune checkpoint inhibitors (ICIs) used off-label, alone or with other treatments
- What this could lead to
- If effective, this could expand treatment options for people with cancers that have not responded to standard therapies, potentially slowing disease progression.
- What could go wrong
- This is an early-phase trial, and off-label use may not work for all cancer types. Immune checkpoint inhibitors can cause serious immune-related side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Froedtert & the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may foretell Radiation's toll on the gut
- Bacterial wall chemical injected into tumors shows promise in early safety trial
- New radiation method aims to shrink large tumors
- Which sedation works best for bile duct procedures? new study aims to find out
- Zapping just a few spots: new hope for patients with worsening metastatic cancer?
- Massive UK study tracks cancer after organ transplants